Participant characteristics and accelerated long-term forgetting scores in cognitively-normal participants with complete biomarker data (n = 306)
Characteristic . | β-Amyloid-negative . | β-Amyloid-positive . |
---|---|---|
n | 211 | 95 |
Percentage female | 49.8 | 52.6 |
Age at ALF assessment, years: mean, SD, (range) | 72.9, 0.64, (71.9, 74.7) | 72.9, 0.59, (71.9, 74.0) |
Childhood cognitive ability, z-score: mean, SD, (range) | 0.48, 0.71, (−1.59, 2.47) | 0.34, 0.71, (−1.37, 2.50) |
Highest educational qualification, %a | ||
None | 12.8 | 20.0 |
Below O-levels (vocational) | 4.7 | 3.2 |
O-levels or equivalent | 26.1 | 30.5 |
A-levels or equivalent | 34.6 | 32.6 |
Degree or equivalent | 21.8 | 13.7 |
Socioeconomic position, % | ||
Unskilled | 0.5 | 0 |
Partly skilled | 5.2 | 5.3 |
Skilled manual | 9.5 | 6.3 |
Skilled non-manual | 21.8 | 24.2 |
Intermediate | 52.6 | 55.8 |
Professional | 10.4 | 8.4 |
Percentage APOE-ε4 carriersa | 19.1 | 54.7 |
Neuroimaging follow-up interval, years: mean, SD, (range) | 2.4, 0.2, (2.0, 3.2) | 2.4, 0.2, (2.2, 3.1) |
White matter hyperintensity volume, ml: median, IQR, (range) | 4.1, 2.0–9.1, (0.1, 44.0) | 4.1, 2.0–9.1, (0.1, 44.0) |
Whole-brain atrophy rateb, ml/year: mean, SD, (range) | −5.7, 3.1, (−15.9, 3.6) | −6.3, 2.9, (−14.1, −0.7) |
Hippocampal atrophy rateb, ml/year: mean, SD, (range) | −0.04, 0.04, (−0.22, 0.07) | −0.04, 0.04, (−0.17, 0.04) |
MyCog subjective cognitive decline score (out of 24): mean, SD, (range) | 4.5, 3.9, (0, 18) | 5.2, 4.0, (0, 21) |
Change in MyCog score: mean, SD, (range) | 0.36, 3.1, (−10, 11) | 0.33, 2.7, (−7, 10) |
Preclinical Alzheimer’s cognitive composite: mean, SD, (range) | 0.09, 0.62, (−1.8, 1.5) | 0.02, 0.66, (−1.9, 1.5) |
Accelerated long-term forgetting scores (%): mean, SD, [median], (range) | ||
Complex figure drawingtotal | 79, 16, [80], (12–122) | 77, 19, [76], (0–111) |
Complex figure drawingoutlinea | 96, 16, [100], (14–200) | 89, 17, [95], (0–118) |
Complex figure drawingdetail | 72, 22, [71], (11–157) | 71, 23, [71], (0–125) |
Face–name | 77, 21, [79], (0–200) | 76, 22, [79], (0–129) |
Characteristic . | β-Amyloid-negative . | β-Amyloid-positive . |
---|---|---|
n | 211 | 95 |
Percentage female | 49.8 | 52.6 |
Age at ALF assessment, years: mean, SD, (range) | 72.9, 0.64, (71.9, 74.7) | 72.9, 0.59, (71.9, 74.0) |
Childhood cognitive ability, z-score: mean, SD, (range) | 0.48, 0.71, (−1.59, 2.47) | 0.34, 0.71, (−1.37, 2.50) |
Highest educational qualification, %a | ||
None | 12.8 | 20.0 |
Below O-levels (vocational) | 4.7 | 3.2 |
O-levels or equivalent | 26.1 | 30.5 |
A-levels or equivalent | 34.6 | 32.6 |
Degree or equivalent | 21.8 | 13.7 |
Socioeconomic position, % | ||
Unskilled | 0.5 | 0 |
Partly skilled | 5.2 | 5.3 |
Skilled manual | 9.5 | 6.3 |
Skilled non-manual | 21.8 | 24.2 |
Intermediate | 52.6 | 55.8 |
Professional | 10.4 | 8.4 |
Percentage APOE-ε4 carriersa | 19.1 | 54.7 |
Neuroimaging follow-up interval, years: mean, SD, (range) | 2.4, 0.2, (2.0, 3.2) | 2.4, 0.2, (2.2, 3.1) |
White matter hyperintensity volume, ml: median, IQR, (range) | 4.1, 2.0–9.1, (0.1, 44.0) | 4.1, 2.0–9.1, (0.1, 44.0) |
Whole-brain atrophy rateb, ml/year: mean, SD, (range) | −5.7, 3.1, (−15.9, 3.6) | −6.3, 2.9, (−14.1, −0.7) |
Hippocampal atrophy rateb, ml/year: mean, SD, (range) | −0.04, 0.04, (−0.22, 0.07) | −0.04, 0.04, (−0.17, 0.04) |
MyCog subjective cognitive decline score (out of 24): mean, SD, (range) | 4.5, 3.9, (0, 18) | 5.2, 4.0, (0, 21) |
Change in MyCog score: mean, SD, (range) | 0.36, 3.1, (−10, 11) | 0.33, 2.7, (−7, 10) |
Preclinical Alzheimer’s cognitive composite: mean, SD, (range) | 0.09, 0.62, (−1.8, 1.5) | 0.02, 0.66, (−1.9, 1.5) |
Accelerated long-term forgetting scores (%): mean, SD, [median], (range) | ||
Complex figure drawingtotal | 79, 16, [80], (12–122) | 77, 19, [76], (0–111) |
Complex figure drawingoutlinea | 96, 16, [100], (14–200) | 89, 17, [95], (0–118) |
Complex figure drawingdetail | 72, 22, [71], (11–157) | 71, 23, [71], (0–125) |
Face–name | 77, 21, [79], (0–200) | 76, 22, [79], (0–129) |
ALF = accelerated long-term forgetting; IQR = interquartile range; SD = standard deviation.
aBased on t-test, ranksum tests or χ2 tests, as appropriate, the difference between amyloid-positive and amyloid-negative groups was statistically significant for education, APOE-ε4 and complex figure drawingoutline.
bAtrophy is represented as change in volume, with negative numbers indicating volume loss.
Participant characteristics and accelerated long-term forgetting scores in cognitively-normal participants with complete biomarker data (n = 306)
Characteristic . | β-Amyloid-negative . | β-Amyloid-positive . |
---|---|---|
n | 211 | 95 |
Percentage female | 49.8 | 52.6 |
Age at ALF assessment, years: mean, SD, (range) | 72.9, 0.64, (71.9, 74.7) | 72.9, 0.59, (71.9, 74.0) |
Childhood cognitive ability, z-score: mean, SD, (range) | 0.48, 0.71, (−1.59, 2.47) | 0.34, 0.71, (−1.37, 2.50) |
Highest educational qualification, %a | ||
None | 12.8 | 20.0 |
Below O-levels (vocational) | 4.7 | 3.2 |
O-levels or equivalent | 26.1 | 30.5 |
A-levels or equivalent | 34.6 | 32.6 |
Degree or equivalent | 21.8 | 13.7 |
Socioeconomic position, % | ||
Unskilled | 0.5 | 0 |
Partly skilled | 5.2 | 5.3 |
Skilled manual | 9.5 | 6.3 |
Skilled non-manual | 21.8 | 24.2 |
Intermediate | 52.6 | 55.8 |
Professional | 10.4 | 8.4 |
Percentage APOE-ε4 carriersa | 19.1 | 54.7 |
Neuroimaging follow-up interval, years: mean, SD, (range) | 2.4, 0.2, (2.0, 3.2) | 2.4, 0.2, (2.2, 3.1) |
White matter hyperintensity volume, ml: median, IQR, (range) | 4.1, 2.0–9.1, (0.1, 44.0) | 4.1, 2.0–9.1, (0.1, 44.0) |
Whole-brain atrophy rateb, ml/year: mean, SD, (range) | −5.7, 3.1, (−15.9, 3.6) | −6.3, 2.9, (−14.1, −0.7) |
Hippocampal atrophy rateb, ml/year: mean, SD, (range) | −0.04, 0.04, (−0.22, 0.07) | −0.04, 0.04, (−0.17, 0.04) |
MyCog subjective cognitive decline score (out of 24): mean, SD, (range) | 4.5, 3.9, (0, 18) | 5.2, 4.0, (0, 21) |
Change in MyCog score: mean, SD, (range) | 0.36, 3.1, (−10, 11) | 0.33, 2.7, (−7, 10) |
Preclinical Alzheimer’s cognitive composite: mean, SD, (range) | 0.09, 0.62, (−1.8, 1.5) | 0.02, 0.66, (−1.9, 1.5) |
Accelerated long-term forgetting scores (%): mean, SD, [median], (range) | ||
Complex figure drawingtotal | 79, 16, [80], (12–122) | 77, 19, [76], (0–111) |
Complex figure drawingoutlinea | 96, 16, [100], (14–200) | 89, 17, [95], (0–118) |
Complex figure drawingdetail | 72, 22, [71], (11–157) | 71, 23, [71], (0–125) |
Face–name | 77, 21, [79], (0–200) | 76, 22, [79], (0–129) |
Characteristic . | β-Amyloid-negative . | β-Amyloid-positive . |
---|---|---|
n | 211 | 95 |
Percentage female | 49.8 | 52.6 |
Age at ALF assessment, years: mean, SD, (range) | 72.9, 0.64, (71.9, 74.7) | 72.9, 0.59, (71.9, 74.0) |
Childhood cognitive ability, z-score: mean, SD, (range) | 0.48, 0.71, (−1.59, 2.47) | 0.34, 0.71, (−1.37, 2.50) |
Highest educational qualification, %a | ||
None | 12.8 | 20.0 |
Below O-levels (vocational) | 4.7 | 3.2 |
O-levels or equivalent | 26.1 | 30.5 |
A-levels or equivalent | 34.6 | 32.6 |
Degree or equivalent | 21.8 | 13.7 |
Socioeconomic position, % | ||
Unskilled | 0.5 | 0 |
Partly skilled | 5.2 | 5.3 |
Skilled manual | 9.5 | 6.3 |
Skilled non-manual | 21.8 | 24.2 |
Intermediate | 52.6 | 55.8 |
Professional | 10.4 | 8.4 |
Percentage APOE-ε4 carriersa | 19.1 | 54.7 |
Neuroimaging follow-up interval, years: mean, SD, (range) | 2.4, 0.2, (2.0, 3.2) | 2.4, 0.2, (2.2, 3.1) |
White matter hyperintensity volume, ml: median, IQR, (range) | 4.1, 2.0–9.1, (0.1, 44.0) | 4.1, 2.0–9.1, (0.1, 44.0) |
Whole-brain atrophy rateb, ml/year: mean, SD, (range) | −5.7, 3.1, (−15.9, 3.6) | −6.3, 2.9, (−14.1, −0.7) |
Hippocampal atrophy rateb, ml/year: mean, SD, (range) | −0.04, 0.04, (−0.22, 0.07) | −0.04, 0.04, (−0.17, 0.04) |
MyCog subjective cognitive decline score (out of 24): mean, SD, (range) | 4.5, 3.9, (0, 18) | 5.2, 4.0, (0, 21) |
Change in MyCog score: mean, SD, (range) | 0.36, 3.1, (−10, 11) | 0.33, 2.7, (−7, 10) |
Preclinical Alzheimer’s cognitive composite: mean, SD, (range) | 0.09, 0.62, (−1.8, 1.5) | 0.02, 0.66, (−1.9, 1.5) |
Accelerated long-term forgetting scores (%): mean, SD, [median], (range) | ||
Complex figure drawingtotal | 79, 16, [80], (12–122) | 77, 19, [76], (0–111) |
Complex figure drawingoutlinea | 96, 16, [100], (14–200) | 89, 17, [95], (0–118) |
Complex figure drawingdetail | 72, 22, [71], (11–157) | 71, 23, [71], (0–125) |
Face–name | 77, 21, [79], (0–200) | 76, 22, [79], (0–129) |
ALF = accelerated long-term forgetting; IQR = interquartile range; SD = standard deviation.
aBased on t-test, ranksum tests or χ2 tests, as appropriate, the difference between amyloid-positive and amyloid-negative groups was statistically significant for education, APOE-ε4 and complex figure drawingoutline.
bAtrophy is represented as change in volume, with negative numbers indicating volume loss.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.